Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Tempus AI, Inc. | TEM | $64.62 | $11.66B | — | |
| Bio-Techne Corporation | TECH | $72.43 | $11.36B | 62.4 | 0.44% |
| Align Technology, Inc. | ALGN | $158.64 | $11.27B | 27.6 | — |
| Axsome Therapeutics, Inc. | AXSM | $206.68 | $10.83B | — | |
| Krystal Biotech, Inc. Common Stock | KRYS | $358.24 | $10.60B | 44.8 | — |
| Globus Medical, Inc. | GMED | $78.29 | $10.51B | 20.0 | — |
| Molina Healthcare, Inc. | MOH | $200.80 | $10.48B | 1,255.0 | — |
| Glaukos Corporation | GKOS | $177.47 | $10.47B | — | |
| Bio-Rad Laboratories, Inc. | BIO | $386.11 | $10.32B | 47.0 | — |
| Insulet Corporation | PODD | $147.48 | $10.23B | 28.3 | — |
| Apogee Therapeutics, Inc. | APGE | $135.07 Sep 3, 2026 | $10.22B | — | |
| Avantor, Inc. | AVTR | $14.97 | $10.13B | — | |
| Cytokinetics, Incorporated | CYTK | $72.72 | $10.11B | — | |
| ABIVAX Société Anonyme | ABVX | $114.79 | $10.02B | — | |
| Henry Schein, Inc. | HSIC | $89.81 | $10.01B | 26.5 | — |
| Universal Health Services, Inc. | UHS | $169.65 | $10.00B | 6.9 | 0.47% |
| Dr. Reddy's Laboratories Limited | RDY | $11.97 | $9.97B | 28.5 | 0.69% |
| The Ensign Group, Inc. | ENSG | $170.79 | $9.95B | 26.8 | 0.15% |
| Oscar Health, Inc. | OSCR | $32.25 | $9.95B | 24.8 | — |
| Praxis Precision Medicines, Inc. | PRAX | $351.81 | $9.82B | — | |
| Nuvalent Inc | NUVL | $123.96 Jul 21, 2026 | $9.81B | — | |
| Kymera Therapeutics, Inc. | KYMR | $117.39 | $9.66B | — | |
| Ionis Pharmaceuticals, Inc. | IONS | $58.09 | $9.65B | — | |
| Repligen Corporation | RGEN | $167.60 | $9.46B | 226.5 | — |
| Protagonist Therapeutics, Inc. | PTGX | $145.72 | $9.43B | 141.5 | — |
| Masimo Corporation | MASI | $179.95 Jun 12, 2026 | $9.36B | 44.2 | — |
| Vaxcyte, Inc. | PCVX | $61.16 | $9.10B | — | |
| Crinetics Pharmaceuticals, Inc. | CRNX | $84.95 Sep 2, 2026 | $9.01B | — | |
| Qiagen N.V. | QGEN | $43.47 | $8.98B | 22.1 | 0.80% |
| Bruker Corporation | BRKR | $58.50 | $8.91B | 0.34% | |
| TG Therapeutics, Inc. | TGTX | $55.99 | $8.57B | 20.4 | — |
| ImmunityBio, Inc. | IBRX | $8.08 | $8.56B | — | |
| 10x Genomics, Inc. | TXG | $62.65 | $8.16B | — | |
| Immunovant, Inc. | IMVT | $39.25 | $8.11B | — | |
| AptarGroup, Inc. | ATR | $127.41 | $8.10B | 23.2 | 1.51% |
| HealthEquity, Inc. | HQY | $96.07 | $7.95B | 35.7 | — |
| Spyre Therapeutics, Inc. | SYRE | $88.98 | $7.85B | — | |
| Twist Bioscience Corporation | TWST | $124.72 | $7.82B | — | |
| Belite Bio, Inc | BLTE | $193.61 | $7.80B | — | |
| Alkermes plc | ALKS | $46.10 | $7.73B | 124.6 | — |
| Apotex Health Corp. | APTX.TO | CA$33.63 | CA$7.68B | 0.18% | |
| Hinge Health, Inc. | HNGE | $92.37 | $7.45B | 11.0 | — |
| Caris Life Sciences, Inc. | CAI | $25.07 | $7.09B | 2.6 | — |
| Rhythm Pharmaceuticals, Inc. Common Stock | RYTM | $102.74 | $7.07B | — | |
| Cidara Therapeutics, Inc. | CDTX | $221.38 Jan 8, 2026 | $6.96B | — | |
| Merus N.V. | MRUS | $90.00 Jan 2, 2026 | $6.83B | — | |
| Chemed Corporation | CHE | $519.84 | $6.79B | 26.4 | 0.53% |
| Scholar Rock Holding Corporation | SRRK | $55.33 | $6.74B | — | |
| Arcellx Inc | ACLX | $115.07 May 15, 2026 | $6.73B | — | |
| PACS Group, Inc. | PACS | $42.50 | $6.73B | 24.9 | — |
Tempus AI, Inc.
Healthcare / Health Information Services
- Market Cap
- $11.66B
- P/E
- unprofitable
Bio-Techne Corporation
Healthcare / Biotechnology
- Market Cap
- $11.36B
- P/E
- 62.4
- Dividend Yield
- 0.44%
Align Technology, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $11.27B
- P/E
- 27.6
Axsome Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $10.83B
- P/E
- unprofitable
Krystal Biotech, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $10.60B
- P/E
- 44.8
Globus Medical, Inc.
Healthcare / Medical Devices
- Market Cap
- $10.51B
- P/E
- 20.0
Molina Healthcare, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $10.48B
- P/E
- 1,255.0
Glaukos Corporation
Healthcare / Medical Devices
- Market Cap
- $10.47B
- P/E
- unprofitable
Bio-Rad Laboratories, Inc.
Healthcare / Medical Devices
- Market Cap
- $10.32B
- P/E
- 47.0
Insulet Corporation
Healthcare / Medical Devices
- Market Cap
- $10.23B
- P/E
- 28.3
Apogee Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $10.22B
- P/E
- unprofitable
Avantor, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $10.13B
- P/E
- unprofitable
Cytokinetics, Incorporated
Healthcare / Biotechnology
- Market Cap
- $10.11B
- P/E
- unprofitable
ABIVAX Société Anonyme
Healthcare / Biotechnology
- Market Cap
- $10.02B
- P/E
- unprofitable
Henry Schein, Inc.
Healthcare / Medical Distribution
- Market Cap
- $10.01B
- P/E
- 26.5
Universal Health Services, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $10.00B
- P/E
- 6.9
- Dividend Yield
- 0.47%
Dr. Reddy's Laboratories Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $9.97B
- P/E
- 28.5
- Dividend Yield
- 0.69%
The Ensign Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $9.95B
- P/E
- 26.8
- Dividend Yield
- 0.15%
Oscar Health, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $9.95B
- P/E
- 24.8
Praxis Precision Medicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.82B
- P/E
- unprofitable
Nuvalent Inc
Healthcare / Biotechnology
- Market Cap
- $9.81B
- P/E
- unprofitable
Kymera Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.66B
- P/E
- unprofitable
Ionis Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.65B
- P/E
- unprofitable
Repligen Corporation
Healthcare / Medical Instruments & Supplies
- Market Cap
- $9.46B
- P/E
- 226.5
Protagonist Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.43B
- P/E
- 141.5
Masimo Corporation
Healthcare / Medical Devices
- Market Cap
- $9.36B
- P/E
- 44.2
Vaxcyte, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.10B
- P/E
- unprofitable
Crinetics Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.01B
- P/E
- unprofitable
Qiagen N.V.
Healthcare / Diagnostics & Research
- Market Cap
- $8.98B
- P/E
- 22.1
- Dividend Yield
- 0.80%
Bruker Corporation
Healthcare / Medical Devices
- Market Cap
- $8.91B
- P/E
- unprofitable
- Dividend Yield
- 0.34%
TG Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.57B
- P/E
- 20.4
ImmunityBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.56B
- P/E
- unprofitable
10x Genomics, Inc.
Healthcare / Medical Devices
- Market Cap
- $8.16B
- P/E
- unprofitable
Immunovant, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.11B
- P/E
- unprofitable
AptarGroup, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $8.10B
- P/E
- 23.2
- Dividend Yield
- 1.51%
HealthEquity, Inc.
Healthcare / Health Information Services
- Market Cap
- $7.95B
- P/E
- 35.7
Spyre Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $7.85B
- P/E
- unprofitable
Twist Bioscience Corporation
Healthcare / Biotechnology
- Market Cap
- $7.82B
- P/E
- unprofitable
Belite Bio, Inc
Healthcare / Biotechnology
- Market Cap
- $7.80B
- P/E
- unprofitable
Alkermes plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $7.73B
- P/E
- 124.6
Apotex Health Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$7.68B
- P/E
- unprofitable
- Dividend Yield
- 0.18%
Hinge Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $7.45B
- P/E
- 11.0
Caris Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $7.09B
- P/E
- 2.6
Rhythm Pharmaceuticals, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $7.07B
- P/E
- unprofitable
Cidara Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.96B
- P/E
- unprofitable
Merus N.V.
Healthcare / Biotechnology
- Market Cap
- $6.83B
- P/E
- unprofitable
Chemed Corporation
Healthcare / Medical Care Facilities
- Market Cap
- $6.79B
- P/E
- 26.4
- Dividend Yield
- 0.53%
Scholar Rock Holding Corporation
Healthcare / Biotechnology
- Market Cap
- $6.74B
- P/E
- unprofitable
Arcellx Inc
Healthcare / Biotechnology
- Market Cap
- $6.73B
- P/E
- unprofitable
PACS Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $6.73B
- P/E
- 24.9
Showing 101–150 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.